Discovery of Novel Blood Biomarkers for PTSD and TBI

Biological Psychiatry 2018; 83(9): S134-135. Supplement
Authored By:
Fossati S, Cejudo JR, Genfi A, Abu-Amara D, Marmar C
The development of blood biomarkers for PTSD and TBI is an extremely critical area of research. Easily detectable blood biomarkers are needed for diagnostic purposes, to establish therapeutic efficacy, to better understand the biology underlying these disorders.
Published in:
Biological Psychiatry

More Publications

August 1, 2023

Journal of Psychopharmacology

Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)

July 6, 2023

Gerontology and Geriatric Medicine

Caring for Dementia Caregivers: Understanding Caregiver Stress During the COVID-19 Pandemic

May 19, 2023

Nature Reviews Neurology

Global synergistic actions to improve brain health for human development

April 20, 2023

Nature Mental Health

Machine learning-based identification of a psychotherapy-predictive electroencephalographic signature in PTSD

February 21, 2023

Translational Psychiatry

Screening for PTSD and TBI in Veterans using Routine Clinical Laboratory Blood Tests

February 13, 2023

Frontiers in Aging Neuroscience

Machine learning within the Parkinson’s progression markers initiative: Review of the current state of affairs